ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Amifampridine Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-19A8297
Home | Market Reports | Health| Health Conditions| Neurological Conditions
Global Amifampridine Market Insights Forecast to 2028
BUY CHAPTERS

Global Amifampridine Market Research Report 2025

Code: QYRE-Auto-19A8297
Report
July 2025
Pages:93
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Jacobus Pharmaceutical
Unichem
BioMarin Pharmaceutical
WOCKHARDT
Glenmark Pharmaceuticals
NORRIS Pharm
BLD Pharm
Biosynth
Innovapharm
Founder Pharma
BroadPharm
CSNpharm
Merck

Amifampridine Market Size

The global market for Amifampridine was valued at US$ 914 million in the year 2024 and is projected to reach a revised size of US$ 1263 million by 2031, growing at a CAGR of 4.8% during the forecast period.

Amifampridine Market

Amifampridine Market

Amifampridine (pyridine-3,4-diamine, 3,4-diaminopyridine, 3,4-DAP) is used as a drug, predominantly in the treatment of a number of rare muscle diseases. The free base form of the drug has been used to treat congenital myasthenic syndromes and Lambert–Eaton myasthenic syndrome (LEMS) through compassionate use programs since the 1990s and was recommended as a first line treatment for LEMS in 2006, using ad hoc forms of the drug, since there was no marketed form
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Amifampridine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Amifampridine.
The Amifampridine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Amifampridine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Amifampridine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Amifampridine Market Report

Report Metric Details
Report Name Amifampridine Market
Accounted market size in year US$ 914 million
Forecasted market size in 2031 US$ 1263 million
CAGR 4.8%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Jacobus Pharmaceutical, Unichem, BioMarin Pharmaceutical, Wockhardt, Glenmark Pharmaceuticals, Norris Pharm, BLD Pharm, Biosynth AG, Innovapharm, Founder Pharma, BroadPharm, CSNpharm, Merck
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Amifampridine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Amifampridine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Amifampridine Market growing?

Ans: The Amifampridine Market witnessing a CAGR of 4.8% during the forecast period 2025-2031.

What is the Amifampridine Market size in 2031?

Ans: The Amifampridine Market size in 2031 will be US$ 1263 million.

Who are the main players in the Amifampridine Market report?

Ans: The main players in the Amifampridine Market are Jacobus Pharmaceutical, Unichem, BioMarin Pharmaceutical, Wockhardt, Glenmark Pharmaceuticals, Norris Pharm, BLD Pharm, Biosynth AG, Innovapharm, Founder Pharma, BroadPharm, CSNpharm, Merck

What are the Application segmentation covered in the Amifampridine Market report?

Ans: The Applications covered in the Amifampridine Market report are Myasthenia Gravis, Potassium Channel Blocker

What are the Type segmentation covered in the Amifampridine Market report?

Ans: The Types covered in the Amifampridine Market report are Generic, Patent

Recommended Reports

API Markets

Neurological Disorders

Pyridine Derivatives

1 Amifampridine Market Overview
1.1 Product Definition
1.2 Amifampridine by Type
1.2.1 Global Amifampridine Market Value Comparison by Type (2024 VS 2031)
1.2.2 Generic
1.2.3 Patent
1.3 Amifampridine by Application
1.3.1 Global Amifampridine Market Value by Application (2024 VS 2031)
1.3.2 Myasthenia Gravis
1.3.3 Potassium Channel Blocker
1.4 Global Amifampridine Market Size Estimates and Forecasts
1.4.1 Global Amifampridine Revenue 2020-2031
1.4.2 Global Amifampridine Sales 2020-2031
1.4.3 Global Amifampridine Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Amifampridine Market Competition by Manufacturers
2.1 Global Amifampridine Sales Market Share by Manufacturers (2020-2025)
2.2 Global Amifampridine Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Amifampridine Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Amifampridine, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Amifampridine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Amifampridine, Product Type & Application
2.7 Global Key Manufacturers of Amifampridine, Date of Enter into This Industry
2.8 Global Amifampridine Market Competitive Situation and Trends
2.8.1 Global Amifampridine Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Amifampridine Players Market Share by Revenue
2.8.3 Global Amifampridine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Amifampridine Market Scenario by Region
3.1 Global Amifampridine Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Amifampridine Sales by Region: 2020-2031
3.2.1 Global Amifampridine Sales by Region: 2020-2025
3.2.2 Global Amifampridine Sales by Region: 2026-2031
3.3 Global Amifampridine Revenue by Region: 2020-2031
3.3.1 Global Amifampridine Revenue by Region: 2020-2025
3.3.2 Global Amifampridine Revenue by Region: 2026-2031
3.4 North America Amifampridine Market Facts & Figures by Country
3.4.1 North America Amifampridine Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Amifampridine Sales by Country (2020-2031)
3.4.3 North America Amifampridine Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Amifampridine Market Facts & Figures by Country
3.5.1 Europe Amifampridine Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Amifampridine Sales by Country (2020-2031)
3.5.3 Europe Amifampridine Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Amifampridine Market Facts & Figures by Region
3.6.1 Asia Pacific Amifampridine Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Amifampridine Sales by Region (2020-2031)
3.6.3 Asia Pacific Amifampridine Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Amifampridine Market Facts & Figures by Country
3.7.1 Latin America Amifampridine Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Amifampridine Sales by Country (2020-2031)
3.7.3 Latin America Amifampridine Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Amifampridine Market Facts & Figures by Country
3.8.1 Middle East and Africa Amifampridine Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Amifampridine Sales by Country (2020-2031)
3.8.3 Middle East and Africa Amifampridine Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Amifampridine Sales by Type (2020-2031)
4.1.1 Global Amifampridine Sales by Type (2020-2025)
4.1.2 Global Amifampridine Sales by Type (2026-2031)
4.1.3 Global Amifampridine Sales Market Share by Type (2020-2031)
4.2 Global Amifampridine Revenue by Type (2020-2031)
4.2.1 Global Amifampridine Revenue by Type (2020-2025)
4.2.2 Global Amifampridine Revenue by Type (2026-2031)
4.2.3 Global Amifampridine Revenue Market Share by Type (2020-2031)
4.3 Global Amifampridine Price by Type (2020-2031)
5 Segment by Application
5.1 Global Amifampridine Sales by Application (2020-2031)
5.1.1 Global Amifampridine Sales by Application (2020-2025)
5.1.2 Global Amifampridine Sales by Application (2026-2031)
5.1.3 Global Amifampridine Sales Market Share by Application (2020-2031)
5.2 Global Amifampridine Revenue by Application (2020-2031)
5.2.1 Global Amifampridine Revenue by Application (2020-2025)
5.2.2 Global Amifampridine Revenue by Application (2026-2031)
5.2.3 Global Amifampridine Revenue Market Share by Application (2020-2031)
5.3 Global Amifampridine Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Jacobus Pharmaceutical
6.1.1 Jacobus Pharmaceutical Company Information
6.1.2 Jacobus Pharmaceutical Description and Business Overview
6.1.3 Jacobus Pharmaceutical Amifampridine Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Jacobus Pharmaceutical Amifampridine Product Portfolio
6.1.5 Jacobus Pharmaceutical Recent Developments/Updates
6.2 Unichem
6.2.1 Unichem Company Information
6.2.2 Unichem Description and Business Overview
6.2.3 Unichem Amifampridine Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Unichem Amifampridine Product Portfolio
6.2.5 Unichem Recent Developments/Updates
6.3 BioMarin Pharmaceutical
6.3.1 BioMarin Pharmaceutical Company Information
6.3.2 BioMarin Pharmaceutical Description and Business Overview
6.3.3 BioMarin Pharmaceutical Amifampridine Sales, Revenue and Gross Margin (2020-2025)
6.3.4 BioMarin Pharmaceutical Amifampridine Product Portfolio
6.3.5 BioMarin Pharmaceutical Recent Developments/Updates
6.4 Wockhardt
6.4.1 Wockhardt Company Information
6.4.2 Wockhardt Description and Business Overview
6.4.3 Wockhardt Amifampridine Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Wockhardt Amifampridine Product Portfolio
6.4.5 Wockhardt Recent Developments/Updates
6.5 Glenmark Pharmaceuticals
6.5.1 Glenmark Pharmaceuticals Company Information
6.5.2 Glenmark Pharmaceuticals Description and Business Overview
6.5.3 Glenmark Pharmaceuticals Amifampridine Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Glenmark Pharmaceuticals Amifampridine Product Portfolio
6.5.5 Glenmark Pharmaceuticals Recent Developments/Updates
6.6 Norris Pharm
6.6.1 Norris Pharm Company Information
6.6.2 Norris Pharm Description and Business Overview
6.6.3 Norris Pharm Amifampridine Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Norris Pharm Amifampridine Product Portfolio
6.6.5 Norris Pharm Recent Developments/Updates
6.7 BLD Pharm
6.7.1 BLD Pharm Company Information
6.7.2 BLD Pharm Description and Business Overview
6.7.3 BLD Pharm Amifampridine Sales, Revenue and Gross Margin (2020-2025)
6.7.4 BLD Pharm Amifampridine Product Portfolio
6.7.5 BLD Pharm Recent Developments/Updates
6.8 Biosynth AG
6.8.1 Biosynth AG Company Information
6.8.2 Biosynth AG Description and Business Overview
6.8.3 Biosynth AG Amifampridine Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Biosynth AG Amifampridine Product Portfolio
6.8.5 Biosynth AG Recent Developments/Updates
6.9 Innovapharm
6.9.1 Innovapharm Company Information
6.9.2 Innovapharm Description and Business Overview
6.9.3 Innovapharm Amifampridine Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Innovapharm Amifampridine Product Portfolio
6.9.5 Innovapharm Recent Developments/Updates
6.10 Founder Pharma
6.10.1 Founder Pharma Company Information
6.10.2 Founder Pharma Description and Business Overview
6.10.3 Founder Pharma Amifampridine Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Founder Pharma Amifampridine Product Portfolio
6.10.5 Founder Pharma Recent Developments/Updates
6.11 BroadPharm
6.11.1 BroadPharm Company Information
6.11.2 BroadPharm Description and Business Overview
6.11.3 BroadPharm Amifampridine Sales, Revenue and Gross Margin (2020-2025)
6.11.4 BroadPharm Amifampridine Product Portfolio
6.11.5 BroadPharm Recent Developments/Updates
6.12 CSNpharm
6.12.1 CSNpharm Company Information
6.12.2 CSNpharm Description and Business Overview
6.12.3 CSNpharm Amifampridine Sales, Revenue and Gross Margin (2020-2025)
6.12.4 CSNpharm Amifampridine Product Portfolio
6.12.5 CSNpharm Recent Developments/Updates
6.13 Merck
6.13.1 Merck Company Information
6.13.2 Merck Description and Business Overview
6.13.3 Merck Amifampridine Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Merck Amifampridine Product Portfolio
6.13.5 Merck Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Amifampridine Industry Chain Analysis
7.2 Amifampridine Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Amifampridine Production Mode & Process Analysis
7.4 Amifampridine Sales and Marketing
7.4.1 Amifampridine Sales Channels
7.4.2 Amifampridine Distributors
7.5 Amifampridine Customer Analysis
8 Amifampridine Market Dynamics
8.1 Amifampridine Industry Trends
8.2 Amifampridine Market Drivers
8.3 Amifampridine Market Challenges
8.4 Amifampridine Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Jacobus Pharmaceutical
Unichem
BioMarin Pharmaceutical
WOCKHARDT
Glenmark Pharmaceuticals
NORRIS Pharm
BLD Pharm
Biosynth
Innovapharm
Founder Pharma
BroadPharm
CSNpharm
Merck
List of Tables
 Table 1. Global Amifampridine Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Amifampridine Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Amifampridine Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Amifampridine Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Amifampridine Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Amifampridine Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Amifampridine Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Amifampridine Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Amifampridine, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Amifampridine, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Amifampridine, Product Type & Application
 Table 12. Global Key Manufacturers of Amifampridine, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Amifampridine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Amifampridine as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Amifampridine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Amifampridine Sales by Region (2020-2025) & (K Units)
 Table 18. Global Amifampridine Sales Market Share by Region (2020-2025)
 Table 19. Global Amifampridine Sales by Region (2026-2031) & (K Units)
 Table 20. Global Amifampridine Sales Market Share by Region (2026-2031)
 Table 21. Global Amifampridine Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Amifampridine Revenue Market Share by Region (2020-2025)
 Table 23. Global Amifampridine Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Amifampridine Revenue Market Share by Region (2026-2031)
 Table 25. North America Amifampridine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Amifampridine Sales by Country (2020-2025) & (K Units)
 Table 27. North America Amifampridine Sales by Country (2026-2031) & (K Units)
 Table 28. North America Amifampridine Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Amifampridine Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Amifampridine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Amifampridine Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Amifampridine Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Amifampridine Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Amifampridine Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Amifampridine Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Amifampridine Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Amifampridine Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Amifampridine Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Amifampridine Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Amifampridine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Amifampridine Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Amifampridine Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Amifampridine Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Amifampridine Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Amifampridine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Amifampridine Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Amifampridine Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Amifampridine Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Amifampridine Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Amifampridine Sales (K Units) by Type (2020-2025)
 Table 51. Global Amifampridine Sales (K Units) by Type (2026-2031)
 Table 52. Global Amifampridine Sales Market Share by Type (2020-2025)
 Table 53. Global Amifampridine Sales Market Share by Type (2026-2031)
 Table 54. Global Amifampridine Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Amifampridine Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Amifampridine Revenue Market Share by Type (2020-2025)
 Table 57. Global Amifampridine Revenue Market Share by Type (2026-2031)
 Table 58. Global Amifampridine Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Amifampridine Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Amifampridine Sales (K Units) by Application (2020-2025)
 Table 61. Global Amifampridine Sales (K Units) by Application (2026-2031)
 Table 62. Global Amifampridine Sales Market Share by Application (2020-2025)
 Table 63. Global Amifampridine Sales Market Share by Application (2026-2031)
 Table 64. Global Amifampridine Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Amifampridine Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Amifampridine Revenue Market Share by Application (2020-2025)
 Table 67. Global Amifampridine Revenue Market Share by Application (2026-2031)
 Table 68. Global Amifampridine Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Amifampridine Price (US$/Unit) by Application (2026-2031)
 Table 70. Jacobus Pharmaceutical Company Information
 Table 71. Jacobus Pharmaceutical Description and Business Overview
 Table 72. Jacobus Pharmaceutical Amifampridine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Jacobus Pharmaceutical Amifampridine Product
 Table 74. Jacobus Pharmaceutical Recent Developments/Updates
 Table 75. Unichem Company Information
 Table 76. Unichem Description and Business Overview
 Table 77. Unichem Amifampridine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Unichem Amifampridine Product
 Table 79. Unichem Recent Developments/Updates
 Table 80. BioMarin Pharmaceutical Company Information
 Table 81. BioMarin Pharmaceutical Description and Business Overview
 Table 82. BioMarin Pharmaceutical Amifampridine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. BioMarin Pharmaceutical Amifampridine Product
 Table 84. BioMarin Pharmaceutical Recent Developments/Updates
 Table 85. Wockhardt Company Information
 Table 86. Wockhardt Description and Business Overview
 Table 87. Wockhardt Amifampridine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Wockhardt Amifampridine Product
 Table 89. Wockhardt Recent Developments/Updates
 Table 90. Glenmark Pharmaceuticals Company Information
 Table 91. Glenmark Pharmaceuticals Description and Business Overview
 Table 92. Glenmark Pharmaceuticals Amifampridine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Glenmark Pharmaceuticals Amifampridine Product
 Table 94. Glenmark Pharmaceuticals Recent Developments/Updates
 Table 95. Norris Pharm Company Information
 Table 96. Norris Pharm Description and Business Overview
 Table 97. Norris Pharm Amifampridine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Norris Pharm Amifampridine Product
 Table 99. Norris Pharm Recent Developments/Updates
 Table 100. BLD Pharm Company Information
 Table 101. BLD Pharm Description and Business Overview
 Table 102. BLD Pharm Amifampridine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. BLD Pharm Amifampridine Product
 Table 104. BLD Pharm Recent Developments/Updates
 Table 105. Biosynth AG Company Information
 Table 106. Biosynth AG Description and Business Overview
 Table 107. Biosynth AG Amifampridine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Biosynth AG Amifampridine Product
 Table 109. Biosynth AG Recent Developments/Updates
 Table 110. Innovapharm Company Information
 Table 111. Innovapharm Description and Business Overview
 Table 112. Innovapharm Amifampridine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Innovapharm Amifampridine Product
 Table 114. Innovapharm Recent Developments/Updates
 Table 115. Founder Pharma Company Information
 Table 116. Founder Pharma Description and Business Overview
 Table 117. Founder Pharma Amifampridine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Founder Pharma Amifampridine Product
 Table 119. Founder Pharma Recent Developments/Updates
 Table 120. BroadPharm Company Information
 Table 121. BroadPharm Description and Business Overview
 Table 122. BroadPharm Amifampridine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. BroadPharm Amifampridine Product
 Table 124. BroadPharm Recent Developments/Updates
 Table 125. CSNpharm Company Information
 Table 126. CSNpharm Description and Business Overview
 Table 127. CSNpharm Amifampridine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. CSNpharm Amifampridine Product
 Table 129. CSNpharm Recent Developments/Updates
 Table 130. Merck Company Information
 Table 131. Merck Description and Business Overview
 Table 132. Merck Amifampridine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. Merck Amifampridine Product
 Table 134. Merck Recent Developments/Updates
 Table 135. Key Raw Materials Lists
 Table 136. Raw Materials Key Suppliers Lists
 Table 137. Amifampridine Distributors List
 Table 138. Amifampridine Customers List
 Table 139. Amifampridine Market Trends
 Table 140. Amifampridine Market Drivers
 Table 141. Amifampridine Market Challenges
 Table 142. Amifampridine Market Restraints
 Table 143. Research Programs/Design for This Report
 Table 144. Key Data Information from Secondary Sources
 Table 145. Key Data Information from Primary Sources
 Table 146. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Amifampridine
 Figure 2. Global Amifampridine Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Amifampridine Market Share by Type: 2024 & 2031
 Figure 4. Generic Product Picture
 Figure 5. Patent Product Picture
 Figure 6. Global Amifampridine Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Amifampridine Market Share by Application: 2024 & 2031
 Figure 8. Myasthenia Gravis
 Figure 9. Potassium Channel Blocker
 Figure 10. Global Amifampridine Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Amifampridine Market Size (2020-2031) & (US$ Million)
 Figure 12. Global Amifampridine Sales (2020-2031) & (K Units)
 Figure 13. Global Amifampridine Average Price (US$/Unit) & (2020-2031)
 Figure 14. Amifampridine Report Years Considered
 Figure 15. Amifampridine Sales Share by Manufacturers in 2024
 Figure 16. Global Amifampridine Revenue Share by Manufacturers in 2024
 Figure 17. Global 5 and 10 Largest Amifampridine Players: Market Share by Revenue in Amifampridine in 2024
 Figure 18. Amifampridine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 19. Global Amifampridine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 20. North America Amifampridine Sales Market Share by Country (2020-2031)
 Figure 21. North America Amifampridine Revenue Market Share by Country (2020-2031)
 Figure 22. United States Amifampridine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 23. Canada Amifampridine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Europe Amifampridine Sales Market Share by Country (2020-2031)
 Figure 25. Europe Amifampridine Revenue Market Share by Country (2020-2031)
 Figure 26. Germany Amifampridine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. France Amifampridine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. U.K. Amifampridine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Italy Amifampridine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Russia Amifampridine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Asia Pacific Amifampridine Sales Market Share by Region (2020-2031)
 Figure 32. Asia Pacific Amifampridine Revenue Market Share by Region (2020-2031)
 Figure 33. China Amifampridine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Japan Amifampridine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. South Korea Amifampridine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. India Amifampridine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Australia Amifampridine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. China Taiwan Amifampridine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Indonesia Amifampridine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Thailand Amifampridine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Malaysia Amifampridine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Latin America Amifampridine Sales Market Share by Country (2020-2031)
 Figure 43. Latin America Amifampridine Revenue Market Share by Country (2020-2031)
 Figure 44. Mexico Amifampridine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Brazil Amifampridine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Argentina Amifampridine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Middle East and Africa Amifampridine Sales Market Share by Country (2020-2031)
 Figure 48. Middle East and Africa Amifampridine Revenue Market Share by Country (2020-2031)
 Figure 49. Turkey Amifampridine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Saudi Arabia Amifampridine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. UAE Amifampridine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Global Sales Market Share of Amifampridine by Type (2020-2031)
 Figure 53. Global Revenue Market Share of Amifampridine by Type (2020-2031)
 Figure 54. Global Amifampridine Price (US$/Unit) by Type (2020-2031)
 Figure 55. Global Sales Market Share of Amifampridine by Application (2020-2031)
 Figure 56. Global Revenue Market Share of Amifampridine by Application (2020-2031)
 Figure 57. Global Amifampridine Price (US$/Unit) by Application (2020-2031)
 Figure 58. Amifampridine Value Chain
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS

Lambert Eaton Myasthenic Syndrome LEMS Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global 4 Dimethylaminopyridine DMAP Market Insights Forecast to 2030
Global Tafamidis API Market Research Report 2024
Global 3 Aminopyridine Market Research Report 2024
Global Lambert Eaton Myasthenic Syndrome Treatment Market Insights Forecast to 2030
Global 4 Amino 2 Methylpyridine Market Research Report 2025
Primidone Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Amitryptyline Market Insights Forecast to 2030
Global 2 Amino 3 trifluoromethyl pyridine Market Research Report 2024
Global 2 Hydroxy 3 trifluoromethylpyridine Market Research Report 2025
Dicyclomine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Myotonic Muscular Dystrophy DMD Treatments Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Selegiline Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Nortriptyline Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Dalfampridine Market Insights Forecast to 2030
Global N N Dimethyl 4 aminopyridine DMAP Market Research Report 2024
Global 2 Aminomethyl Pyridine Market Research Report 2025
Global 2 6 Diaminopyridine Market Research Report 2024
Global Pharmaceutical Grade 3 Aminopyridine Market Research Report 2024
3 4 Pyridinedicarboximide Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Attention Deficit Hyperactivity Disorder (ADHD) Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-13Z8760
Tue Sep 09 00:00:00 UTC 2025

Add to Cart

Global Intracranial Pressure (ICP) Monitoring Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-37L4006
Mon Sep 08 00:00:00 UTC 2025

Add to Cart

Global Brain Disease Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-12P6151
Mon Sep 08 00:00:00 UTC 2025

Add to Cart

Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3X6389
Mon Sep 08 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions